Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Eagle High Plantations Tbk. (BWPT) vs Dharma Polimetal Tbk. (DRMA) Price & Performance

Eagle High Plantations Tbk.Trade
Dharma Polimetal Tbk.Trade

Price performance (Past 24H)

Key statistics

Eagle High Plantations Tbk. vs Dharma Polimetal Tbk. — how do they compare? Eagle High Plantations Tbk. trades at Rp75 (market cap 2.36T, 28.68M 24h volume), while Dharma Polimetal Tbk. trades at Rp930 (market cap 4.35T, 825.7K 24h volume). The key difference: Dharma Polimetal Tbk. is the larger of the two by market cap, and Eagle High Plantations Tbk. is more actively traded (28.68M versus 825.7K). Which is the better fit depends on your goals.

BWPTDRMA
Market Cap
2.36T4.35T
Volume
28.68M825.7K
Lot
286.78K8.26K
Turnover
2.15B768.05M
Average Price
74.85930.18
Value
2.15B768.05M
Indicative Equilibrium Price
75930
Indicative Equilibrium Volume
7.15K2

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BWPT
View details
DRMA
View details

About Eagle High Plantations Tbk.

PT Eagle High Plantations Tbk formerly PT BW Plantation (the company) was established under its original name of PT Bumi Perdana Prima International base on notarial deed No.13 of Mr Paulus Widodo, S.H, dated on Nov 6, 2000. The Company’s articles of association has been amended several times, most recently by notarial deed No. 67 of Mr Muhamad Hanafi, S.H., dated Feb 18, 2008, concerning among others, the change in the Company’s name, par value, authorized share, paid up capital, board of commission and director, and public offering.

Read more on BWPT

About Dharma Polimetal Tbk.

PT Dharma Polimetal Tbk (“the Company”) was established in the Republic of Indonesia on 27 March based on Notarial deed No. 74 of Rukmasanti Hardjasatya, S.H. The Company begin opertions on year 1989 and commenced its commercial activities since 1990. The Company’s Majority shareholder is PT Dharma Inti Anugerah, established in Republic Indonesia on 20 November 2003.

Read more on DRMA